2- (2- chlorophenyl)- 3- (4- chlorophenyl)- 7- (2,2- difluoropropyl)- 6,7- dihydro- 2H- pyrazolo(3,4- f)(1,4)oxazepin- 8(5H)- one

putative anti-obesity agent; structure in first source

Also Known As:

PF 514273; PF-514273; PF514273

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Inflammation (Inflammations) 01/01/2018 - "After inflammation, 20:4-NAPE increased sEPSCs frequency in the presence of PF514273 and this increase was blocked by SB366791. " 01/01/2018 - "The inhibitory effect of 20:4-NAPE was sensitive to CB1 receptor antagonist PF514273 (0.2 μM) in both conditions, but to the TRPV1 antagonist SB366791 (10 μM) only after inflammation. "

1.	CB1 Cannabinoid Receptor (CB1 Receptor)
2.	N- (3- methoxyphenyl)- 4- chlorocinnamanilide
3.	1,2- dioleoyl- sn- glycero- 3- phosphoethanolamine- N- arachidonoyl